(4aS,7S)-5,6,7,8-Tetrahydro-7-hydroxy-7-(1-hydroxy-1-methylethyl)-1,4a-dimethyl-2(4aH)-naphthalenone
Canusesnol A
CAS: 816456-90-3
Molecular Formula: C15H22O3
(4aS,7S)-5,6,7,8-Tetrahydro-7-hydroxy-7-(1-hydroxy-1-methylethyl)-1,4a-dimethyl-2(4aH)-naphthalenone - Names and Identifiers
(4aS,7S)-5,6,7,8-Tetrahydro-7-hydroxy-7-(1-hydroxy-1-methylethyl)-1,4a-dimethyl-2(4aH)-naphthalenone - Physico-chemical Properties
| Molecular Formula | C15H22O3 |
| Molar Mass | 250.33338 |
| Density | 1.14±0.1 g/cm3(Predicted) |
| Boling Point | 394.6±42.0 °C(Predicted) |
| Specific Rotation(α) | ?37.5 (c, 0.1 in MeOH) |
| Appearance | oily |
| pKa | 14.35±0.60(Predicted) |
| Storage Condition | 2-8℃ |
(4aS,7S)-5,6,7,8-Tetrahydro-7-hydroxy-7-(1-hydroxy-1-methylethyl)-1,4a-dimethyl-2(4aH)-naphthalenone - Introduction
Canusesnol A is A natural product belonging to the class of sesquiterpenes. It was isolated for the first time from the tobacco tree cansuse subgenus in South Africa. Canusesnol A is A white solid with A strong aroma.
Canusesnol A has A variety of medicinal uses. Studies have shown that it has potential for anticancer and antibacterial effects. It has also been used to treat inflammation and heal wounds, and has been found to have therapeutic potential for neurodegenerative diseases.
The preparation method of Canusesnol A is usually obtained by extracting from tobacco trees in South Africa. The extraction process generally includes steps of mild solvent extraction, fractionation, and purification.
Regarding the safety information of Canusesnol A, no large-scale studies have been conducted on its toxicity and side effects. Therefore, proper evaluation and strict safety measures should be taken before use to avoid potential risks. Appropriate laboratory safety procedures should be followed and should only be performed by trained personnel.
Canusesnol A has A variety of medicinal uses. Studies have shown that it has potential for anticancer and antibacterial effects. It has also been used to treat inflammation and heal wounds, and has been found to have therapeutic potential for neurodegenerative diseases.
The preparation method of Canusesnol A is usually obtained by extracting from tobacco trees in South Africa. The extraction process generally includes steps of mild solvent extraction, fractionation, and purification.
Regarding the safety information of Canusesnol A, no large-scale studies have been conducted on its toxicity and side effects. Therefore, proper evaluation and strict safety measures should be taken before use to avoid potential risks. Appropriate laboratory safety procedures should be followed and should only be performed by trained personnel.
Last Update：2024-04-09 21:54:55
Supplier List
Product Name: Canusesnol A Visit Supplier Webpage Request for quotation
CAS: 816456-90-3
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
CAS: 816456-90-3
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
Product Name: Canusesnol A Visit Supplier Webpage Request for quotation
CAS: 816456-90-3
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
CAS: 816456-90-3
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
View History
(4aS,7S)-5,6,7,8-Tetrahydro-7-hydroxy-7-(1-hydroxy-1-methylethyl)-1,4a-dimethyl-2(4aH)-naphthalenone